Garcia del Pozo Javier, Carvajal Alfonso, Viloria Jose Maria, Velasco Alfonso, Garcia del Pozo Victorina
Institute of Pharmacoepidemiology, University of Valladolid, Valladolid, Spain.
Eur J Clin Pharmacol. 2008 Apr;64(4):411-5. doi: 10.1007/s00228-007-0419-9. Epub 2007 Dec 20.
During the past few years there have been changes in the availability of opioids in Spain, and new policies on palliative care have been implemented. The aim of this study was to describe the new pattern of opioid consumption in Spain and the associated economic impact.
A search in the ECOM (Especialidades Consumo de Medicamentos) database of the Ministry of Health and Consumer Affairs for the 1992-2006 period was carried out. This database contains information on prescriptions of primary care medicines that are covered by the National Health System in Spain.
Since 1992, overall opioid consumption has increased 14-fold, from 0.3 DDD/1000 inhabitants per day to 4.4 DDD/1000 inhabitants per day. For the six drugs that require a special prescription form--morphine, methadone, oxycodone pethidine, tilidine and fentanyl--consumption increased from 0.1 DDD/1000 inhabitants per day in 1992 to 1.2 in 2006. During this same period, the total costs of these prescriptions increased by 36.8-fold, and the cost per day and per patient doubled.
A huge increase in opioid consumption has occurred during the time period covered by this study, with fentanyl consumption accounting for most of that increase. Although oral morphine is the first-choice drug among strong opioids, fentanyl is currently the most consumed.
在过去几年中,西班牙阿片类药物的可获得性发生了变化,并且实施了新的姑息治疗政策。本研究的目的是描述西班牙阿片类药物消费的新模式及其相关的经济影响。
对1992 - 2006年期间卫生与消费者事务部的ECOM(药物消费专科)数据库进行了检索。该数据库包含西班牙国家卫生系统所涵盖的初级保健药物处方信息。
自1992年以来,阿片类药物的总体消费量增长了14倍,从每天每1000居民0.3限定日剂量增加到每天每1000居民4.4限定日剂量。对于六种需要特殊处方形式的药物——吗啡、美沙酮、羟考酮、哌替啶、替利定和芬太尼——消费量从1992年的每天每1000居民0.1限定日剂量增加到2006年的1.2。在同一时期,这些处方的总成本增加了36.8倍,每天和每位患者的成本翻了一番。
在本研究涵盖的时间段内,阿片类药物的消费量大幅增加,其中芬太尼的消费增长占大部分。尽管口服吗啡是强效阿片类药物中的首选药物,但目前芬太尼的消费量最大。